MoaData Targets CIS Market with Proven 'AI Healthcare' Platform from Thailand's BDMS

AI specialist company MoaData is set to target the Commonwealth of Independent States (CIS) market, leveraging its experience in AI healthcare business with Thailand’s largest hospital network, BDMS. The company plans to expand its international business by introducing a predictive and preventive healthcare platform that analyzes health checkup data and daily life data collected from wearable devices such as smart rings using AI.

On August 20, MoaData announced that it will apply the technology and localization experience gained from its AI health management platform project, developed in collaboration with N Health, a subsidiary of the BDMS Group, to CIS countries.

The platform promoted by MoaData advances beyond the conventional method of analyzing health checkup results at a single point in time. It combines health checkup data with lifelog information—continuously accumulated data such as heart rate, blood oxygen level, body temperature, physical activity, and sleep, gathered through wearable devices—to analyze changes in an individual's health status over time.

The AI detects abnormal patterns differing from daily norms based on long-term accumulated data to identify health risk possibilities early. The platform is designed not only to analyze biological age and disease risk by monitoring lifelog data, but also to detect early signs of health issues and provide personalized health management information all within a single service.

MoaData’s push into the CIS market is backed by its localization experience gained through business in Thailand. In the global digital healthcare sector, differences in national healthcare systems, hospital operations, health checkup protocols, and regulations on personal and medical data mean that simply exporting domestic software has clear limitations for business expansion.

Throughout its work in Thailand, MoaData gained experience in all areas of digital healthcare—from connecting with local medical institutions and building systems, to localizing its AI platform, integrating wearable devices, and operating services. The company’s strategy is to tailor this experience for the individual medical environments found across CIS countries.

The company’s overseas business strategy is summed up as “from Korea to Thailand, from Thailand to CIS.” AI technology developed domestically is localized through large medical networks in Thailand, and the global healthcare business experience and operational models gathered there are then extended to CIS regions.

Within the CIS market, MoaData plans to expand its customer base beyond hospitals and health checkup centers to include insurers, corporations, telecom operators, and government agencies. First, the company intends to offer AI health analysis services using local medical institutions’ health checkup data, and then secure real-time health information through integration with wearable devices such as smart rings.

As data accumulation increases, the company will enhance its business into a predictive and preventive platform where AI analyzes individual health risks and abnormal signs, ultimately delivering personalized health management services.

MoaData’s existing AI abnormality detection technology will also form the foundation of its healthcare business. Until now, the company has focused mainly on AIOps technology, which preemptively detects potential system failures by analyzing large-scale data from information and communication technology (ICT) systems using AI.

This approach—using technology that detects abnormal patterns before system failures occur—will now be adapted to analyze changes in human health data, aiming to identify deviations from personal norms and detect health risks at an early stage by analyzing long-term accumulated personal health data.

The business model will also expand from a traditional business-to-consumer (B2C) focus to include business-to-business (B2B) and business-to-government (B2G) models. The company plans to widen its scope beyond the private sector—such as employee health management, insurance-linked healthcare, and patient health management at hospitals—to include public healthcare and nationwide digital healthcare platforms.

A MoaData representative stated, “Through our project with Thailand’s BDMS Group, we have accumulated actual experience in applying AI technology to overseas medical environments and integrating data and systems from local medical institutions,” and added, “This experience will be a valuable asset as we expand into the global digital healthcare market in the future.”

The spokesperson also commented, “We will gradually expand into the market by localizing our predictive and preventive healthcare model, which analyzes health checkup and smart ring-based lifelog data using AI, to fit the medical environments of CIS countries.”

This content was produced with the assistance of AI translation services.